FDA Approved Putting Computers in Human Brains

Neuralink, the brain-computer interface company founded by Elon Musk, has made an intriguing announcement that has captured the attention of the scientific community and the general public alike.

According to Neuralink, the company has received approval from the Food and Drug Administration (FDA) to conduct its first in-human clinical study. This news marks a significant milestone for Neuralink, as it paves the way for actual humans to receive implantation of Neuralink’s device in their heads.

This recent development comes on the heels of Elon Musk’s claim in November that Neuralink was approximately six months away from conducting its first human trial. Surprisingly, it appears that Musk’s promise is on track, a rarity for his ambitious ventures. While the announcement of a future human trial is noteworthy, the real significance lies in the outcomes of this trial.

What makes it particularly intriguing is that it involves Elon Musk, an influential figure in the technology industry, attaching a device directly to a human brain. This raises questions about who would be willing to participate in such an experiment and their motivations.

Will it be individuals with crucial medical needs, or those seeking to bask in the limelight alongside Musk? Furthermore, there is even speculation as to whether Elon Musk himself might be a participant, as he has expressed his intention to have the Neuralink device implanted in his own head in the future.

However, amidst the anticipation and excitement surrounding Neuralink’s progress, the company has faced some controversy. Neuralink has been accused of mistreating its monkey test subjects, an allegation the company vehemently denies.

Additionally, there are ongoing investigations into the transportation of contaminated devices removed from monkeys, adding another layer of concern. In fact, an earlier application by Neuralink for human trials was rejected by the FDA in early 2022, citing numerous issues that needed to be addressed.

It’s important to note that Neuralink is not the first company to delve into brain-computer interfaces for humans. Synchron, another company in this field, gained FDA approval to initiate trials in the United States in 2021 and announced the first brain-computer implant in the country last July.

In January of this year, Synchron published the results of a previous study involving four human patients in Australia, further highlighting the progress being made in this area.

If you find yourself captivated by the idea of being part of Neuralink’s groundbreaking trial, unfortunately, you’ll have to wait for further updates. Neuralink has stated that recruitment is not yet open, but they will provide more information “soon.”

As the company continues to make strides and overcome regulatory hurdles, it remains to be seen how this technology will evolve and impact the future of neuroscience and human-machine interfaces.

Leave a Reply

Powered by WordPress.com.

Up ↑

%d bloggers like this: